ARI103094-Follow-Up Study for REDUCE Study Subjects [FOLLOW-UP OF 700012063]

Trial Profile

ARI103094-Follow-Up Study for REDUCE Study Subjects [FOLLOW-UP OF 700012063]

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Jul 2017

At a glance

  • Drugs Dutasteride (Primary)
  • Indications Benign prostatic hyperplasia; Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top